News

British Columbia’s school-based human papillomavirus (HPV) immunization program is reducing rates of cervical pre-cancer in B.C. women, according to a new study.

Researchers report in Nature Medicine a potential new treatment strategy for autism spectrum disorder – for which many cases are linked to mutated PTEN. Now, using Pten-deficient mice, researchers discover that a previously unexplored pathway goes “awry” in the brain, and by “rescuing” this pathway, it is possible to reverse behavioral and neurophysiological abnormalities.

Mathematicians have made a breakthrough that could help scientists speed up the supercomputers used to model protein folding and other complex atomic-scale problems.

Teva UK Ltd is recalling unexpired stock of certain batches of two types of Ranitidine medicines – used to treat conditions such as heartburn and stomach ulcers.

Medical marijuana shows early promise to lessen opioid use and potential abuse, according to a systematic review of published studies being presented at the ANESTHESIOLOGY® 2019 annual meeting. However, more rigorous scientific research must be conducted to determine if there truly are pain relief benefits to medical marijuana that can help ease chronic pain and outweigh potential risks.

Study reports the discovery of a compound that is capable of killing chemotherapy-resistant glioblastoma-initiating cells (GICs), raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity.

Creatine serves as a molecular battery for immune cells by storing and distributing energy to fuel their fight against cancer, according to a new study.

Not-for-profit Jisc and the Microbiology Society announce a pilot transitional open access agreement. The "Publish and Read" deal will allow researchers at participating institutions to publish an unlimited number of open-access articles, as well as access to the society’s full portfolio in return for a cost neutral fixed fee.

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.